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was 7% higher (relative risk 5 1.07) for a CRP concentrationAssociation of morbidity with markers of nutrition and in-
of 0.92 mg/dl and was 30% (relative risk 5 1.30) higher for aflammation in chronic hemodialysis patients: A prospective
CRP concentration of 3.4 mg/dl. When a reactance value ofstudy.
70 ohms was considered as a reference range with a relativeBackground. Numerous studies suggest a strong association
risk of 1.0, the relative risk of hospitalization increased to 1.09between nutrition and clinical outcome in chronic hemodialysis
for a reactance value of 43 ohms and further increased to 1.14(CHD) patients. Nevertheless, the pathophysiological link be-
for a reactance value of 31 ohms.tween malnutrition and morbidity remains to be clarified. In
Conclusions. The results of this study strongly indicate thataddition, recent evidence suggests that nutritional indices may
both nutritional status and inflammatory response are indepen-reflect an inflammatory response, as well as protein–calorie
dent predictors of hospitalization in CHD patients. CRP andmalnutrition. In this study, we prospectively assessed the rela-
reactance values by BIA are reliable indicators of hospitaliza-tive importance of markers of nutritional status and inflamma-
tion. Visceral proteins such as serum albumin, prealbumin, andtory response as determinants of hospitalization in CHD pa-
transferrin are influenced by inflammation when predictingtients.
hospitalization. When short-term clinical outcomes such as hos-Methods. The study consisted of serial measurements of con-
pitalizations are considered, markers of both inflammation andcentrations of serum albumin, creatinine, transferrin, prealbu-
nutrition should be evaluated.min, C-reactive protein (CRP), and reactance values by bio-
electrical impedance analysis (BIA) as an indirect measure of
lean body mass every 3 months over a period of 15 months in
73 CHD patients. Outcome was determined by hospitalizations The mortality and morbidity rate of treated end-stageover the subsequent three months following each collection of
renal disease (ESRD) patients remain high [1, 2]. In thedata.
United States, the life expectancy of ESRD patients isResults. Patients who required hospitalization in the three
months following each of the measurement sets had signifi- 20 to 25 years less than the normal age-sex-race–matched
cantly different values for all parameters than patients who U.S. population over the age of 45. Despite recent ad-
were not hospitalized. Thus, serum albumin (3.93 6 0.39 vs. vances in our understanding of the uremic state and3.74 6 0.39 g/dl), serum creatinine (11.0 6 3.7 vs. 9.1 6 3.5
improvements in the science and technology of renalmg/dl), serum transferrin (181 6 35 vs. 170 6 34 mg/dl), serum
replacement therapy, the prognosis of this patient popu-prealbumin (33.6 6 9.2 vs. 30.0 6 10.1 mg/dl), and reactance
(50.4 6 15.6 vs. 43.0 6 13.0 ohms) were higher for patients lation remains poor.
not hospitalized, whereas CRP (0.78 6 0.89 vs. 2.25 6 2.72 Among many factors, including treatment characteris-
mg/dl) was lower in patients who were not hospitalized. All tics and comorbid conditions, protein and calorie malnu-differences were statistically significant (P , 0.05 for all param-
trition has been shown to be a major risk factor foreters). When multivariate analysis was performed, serum CRP
increased mortality in the chronic hemodialysis (CHD)and reactance values were the only statistically significant pre-
dictors of hospitalization (P , 0.05 for both). When a serum patient population [3–6]. Protein and calorie malnutri-
CRP concentration of 0.12 mg/dl was considered as a reference tion can be characterized by an insidious loss of somatic
range (relative risk 1.0), the relative risk for hospitalization proteins, reflected by a decrease in lean body mass and
serum creatinine concentration, as well as by visceral
proteins, as assessed by serum albumin, prealbumin, andKey words: malnutrition, C-reative protein, inflammatory response,
end-stage renal disease, uremia, bioelectrical impedance analysis. transferrin concentrations. Using these indices, several
prospective and retrospective studies have suggestedReceived for publication January 26, 1998
that protein and calorie malnutrition is a significant de-and in revised form November 3, 1998
Accepted for publication December 17, 1998 terminant of clinical outcomes in chronic dialysis patients
[7–14]. 1999 by the International Society of Nephrology
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Table 1. Demographic characteristics of the sion criteria included CHD for at least three months and
study patients (N 5 73)
the ability to sign an informed consent form. The study
Gender (M/F) 53%M/47%F period was between February 1, 1996, through May 31,
Race 27% White/73% African American 1997, and included all consenting patients surveyed byAge years 56613
May 31, 1996. The overall participation rate into theCause of ESRD 30% Diabetes
46% Hypertension study was approximately 60%. Patients were censored
4% Glomerulonephritis from the study if death or transplantation occurred or4% PKD
if they were either transferred to another facility or16% Unknown
switched to peritoneal dialysis. The study protocol wasAbbreviations are: M, male; F, female; PKD, polycystic kidney disease.
approved by the institutional review board, and a written
informed consent form was obtained from patients.
Study designDespite the numerous studies suggesting the strong
association between malnutrition and mortality in CHD The study was a prospective cohort design. There were
patients, the pathophysiological link between these two no interventions specific to the study, and dialysis pre-
conditions remains to be clarified. Complicating this link- scriptions were determined by the attending nephrolo-
age is the fact that serum albumin, the most common gist. The study consisted of serial measurements of study
and usually the singular parameter used for assessment parameters every 3 months over a period of 15 months.
of nutritional status, and more recent nutritional indices The study parameters were serum albumin, creatinine,
such as serum prealbumin and transferrin are also acute- transferrin, prealbumin, and C-reactive protein (CRP)
phase reactants and their serum concentrations are pro- as biochemical parameters, as well as reactance values
foundly affected by the presence of an inflammatory by bioelectrical impedance analysis (BIA) as an indirect
response. Therefore, it is not clear whether clinical out- measure of lean body mass.
come in CHD patients associated with these markers is a Sample collection was completed within the first week
reflection of nutritional status or inflammatory response. of each month of data analysis. Blood samples were
Indeed, recent studies suggest that a combined state of collected predialysis in a nonfasting state from each study
poor nutritional status and inflammation predisposes patient by the study coordinator. On the day of the
ESRD patients to poor clinical outcome [15]. sample collection, patients underwent BIA at approxi-
Another limitation of the available studies on the asso- mately 30-minutes postdialysis.
ciation of nutrition with patient outcome is that these During the study period, the study coordinator moni-
studies are, in general, a cross-sectional design. Longitu- tored all morbid events for all study patients. Specific
dinal studies evaluating the clinical significance of nutri- causes of hospitalization (grouped as infectious causes,
tional parameters over time in CHD are lacking. Finally, cardiac causes, vascular access-related causes, and other
the majority of the studies on clinical outcomes are lim- causes classified according to ICD-9 codes) were also
ited to mortality, and studies on morbidity (that is, hospi- monitored. All hospitalizations were recorded for each
talization) are few. three-month interval following the data collection. In an
In this prospective study, we evaluated the association attempt to find the predictive value of these parameters
of several well-defined markers of nutritional status, as in terms of near-term morbidity, analysis with regard
well as a marker of inflammation with hospitalization to hospitalization was limited to the subsequent three
over a period of 15 months in a stable CHD patient popu- months following each data collection. Of note, the final
lation. Our specific aim was to evaluate the relative im- analysis does not include vascular access-related hospi-
portance of nutritional status and inflammatory response talization.
as determinants of hospitalization in CHD patients. Mortality data were also collected during the study
period. The overall mortality of the study patients was
9.6% (seven deaths in 73 patients) during the 15-monthMETHODS
study period, an annual mortality rate of 7.7%. Because
Patient characteristics this rate was insignificant for any meaningful statistical
A total of 73 patients on CHD were included in the analysis, mortality was not analyzed as an outcome mea-
study. The demographic characteristics of the study pop- sure in this study.
ulation are depicted in Table 1. In general, the study All patients underwent formal urea kinetic modeling
population differed little from the average characteristics once a month during the study period. The minimum
of the CHD population reported by the United States dialysis dose practiced at the dialysis unit was Kt/V
Renal Data System. All patients dialyzed at the Vander- greater than or equal to 1.4 (single pool). All patients
bilt University Medical Center Outpatient Hemodialysis were dialyzed with biocompatible membranes. Study pa-
tients’ calcium, phosphorus, total bicarbonate, and he-Center were asked to participate in the study. The inclu-
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matocrit levels were included in regular patient monthly cance of interactions. None of the two-way interaction
terms reached the 5% statistically significant level in thelaboratory reports. Every effort was made to keep labo-
ratory parameters within acceptable ranges through es- full statistical model; therefore, the final statistical model
in this article does not include such interaction terms.tablished protocols. Recombinant human erythropoietin
was prescribed to keep hematocrit within the range of Data are presented as mean 6 sd. Differences were
considered statistically significant when P was less than33 to 36%.
All measurements were done at the clinical and special 0.05. All statistical analyses were completed using SAS
version 6.12.chemistry laboratories at Vanderbilt University Medical
Center. Serum albumin was analyzed using bromcresol
green technique. Serum prealbumin was analyzed by an
RESULTS
antigen–antibody complex assay, and serum transferrin
The mean values for the biochemical parameters thatwas analyzed by turbidimetric reading (Hitachi 717).
were followed during the study period are depicted inCRP was measured using nephelometric analysis.
Table 2. The overall 15-month mean concentration forBioelectrical impedance analysis was done using a hand-
serum albumin was 3.88 6 0.40 g/dl (range 1.40 to 4.80held device (Quantum, BIA 101Q; RJL Systems, Clinton
g/dl), for serum creatinine 10.5 6 3.7 mg/dl (range 1.70Twp., MI, USA). All tests were done 30 minutes follow-
to 24.3 mg/dl), for serum prealbumin 32.6 6 9.6 mg/dling the termination of hemodialysis. In brief, subjects
(range 8.8 to 59.0 mg/dl), for serum transferrin 179 6were placed in a supine position with their arms at but
35 mg/dl (range 107 to 347 mg/dl), and for serum CRPnot touching their sides and with their legs separated.
1.18 6 1.73 mg/dl (range 0.09 to 11.8 mg/dl). The re-Electrodes were attached to their right hand and foot,
actance values obtained by BIA are also depicted inand a high-frequency, alternating low voltage (approxi-
Table 2. The overall mean reactance value was 48.5 6mately 1 kHz) was passed across the limbs; the current
15.3 ohms (range 14 to 95 ohms).passing through the body was measured. From this mea-
During the study period (3 months following eachsurement, reactance and resistance values were measured.
data collection for a total of 15 months), a total of 84The validity of BIA in CHD patients has been proven
nonvascular access-related hospitalization episodes wereusing deuterium oxide and sodium bromide isotope dilu-
recorded. Twenty-four out of 73 patients were not hospi-tion studies [16]. These values allowed the calculation of
talized during the study. Of those 84 hospitalizationsbody composition, including lean body mass according to
within each three-month period, 25 patients were hospi-standard equations from the manufacturer. In this study,
talized only once. Fourteen were hospitalized twice, andreactance values were used as a marker of metabolically
10 were hospitalized three times or more. For any three-active body compartment, that is, body cell mass or lean
month period, only the initial hospitalizations followingbody mass, to eliminate any potential flaws associated
data collection were used for analysis. The median lengthwith equations that use normal population adjustments.
of stay was five days for the hospitalizations (range 1 to
Statistical analysis 59 days).
Because the primary outcome of the study was hospi-Demographic information and descriptive statistics
talization, the study parameters were analyzed accordingare presented in table form. Data were transformed using
to subsequent hospitalizations over the three monthsappropriate transformations such as the log or square
following the collection of data. Specifically, the meanroot. Tests of hypotheses concerning comparisons were
(6 sd) of the study parameters in patients without subse-completed using the paired t-test or the Wilcoxon rank
quent hospitalization was compared with the mean (6 sd)sum test.
of the study parameters in patients with subsequent hos-For both count and binary multiple time points data,
pitalization within the following three months. Table 2the generalized estimating equation (GEE) method sta-
shows the mean values for each study parameter groupedtistical procedure was used [17, 18]. This method adjusts
according to whether patients were hospitalized or notfor an intracorrelation effect for the patients with multi-
hospitalized in the subsequent three months. As can beple hospitalizations and is a repeated-measures analysis
seen, all study parameters were statistically significantlyfor correlated dichotomous outcomes (hospitalization
different between the two groups. Of the biochemicalyes or no) and a set of predictors. Specifically, multiple
nutritional markers, mean serum albumin concentrationmeasures over time for each study subject were taken
was 3.93 6 0.39 g/dl for patients who did not have ainto account and adjusted by this method. The possible
subsequent hospitalization as compared with 3.74 6 0.39two-way interactions such as the interaction between
g/dl for patients who had a hospitalization episode (P ,serum albumin and CRP, the interaction between serum
0.05). The mean serum creatinine concentration wasalbumin and serum prealbumin, and the interaction be-
11.0 6 3.7 mg/dl for patients who did not have a subse-tween serum creatinine and reactance were included in
the full statistical model for testing the statistical signifi- quent hospitalization as compared with 9.1 6 3.5 mg/dl
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Table 2. The mean values for each study parameter grouped according to patients with subsequent hospitalization
or patients with no hospitalization
SCr SPrealb STransferrinCRP SAlb Reactance
mg/dl g/dl mg/dl ohms
All (12-month average) 1.18 61.73 3.88 60.40 10.5 63.7 32.6 69.6 179 635 48.5615.3
Hospitalization 2.2562.72c 3.7460.39a 9.163.5b 30.0610.1a 170634b 43.0613.0c
No hospitalization 0.7860.89 3.93 60.39 11.0 63.7 33.6 69.2 181 635 50.4615.6
Abbreviations are: CRP, C-reative protein, Salb, serum albumin; SCr, serum creatinine; SPrealb, serum prealbumin; STranferrin, serum transferrin.
a P , 0.05 vs. No hospitalization
b P , 0.01 vs. No hospitalization
c P , 0.001 vs. No hospitalization
Fig. 1. The percentage of hospitalized patients for each quartile of Fig. 2. The percentage of hospitalized patients for each quartile of
serum albumin concentrations (P , 0.05 by regression analysis). reactance values (P , 0.001 by regression analysis).
for patients who had a hospitalization episode (P ,
0.005). The mean serum prealbumin concentration was
33.6 6 9.2 mg/dl for nonhospitalized patients versus 30.0 6
10.1 mg/dl for hospitalized patients (P , 0.05). The mean
serum transferrin concentration was 181 6 35 mg/dl for
patients who did not have a subsequent hospitalization
as compared with 170 6 34 mg/dl for patients who had
a hospitalization episode (P 5 0.009). The reactance
values as marker for lean body mass were 50.4 6 15.6
ohms for patients who did not have a subsequent hospi-
talization compared with 43.0 6 13.0 ohms for patients
who had a hospitalization episode (P 5 0.0004). Fig. 3. The percentage of hospitalized patients for each quartile of
serum C-reactive protein concentrations (P , 0.0001 by regressionSerum CRP concentration as a marker of inflamma-
analysis).tion also showed significant difference between the two
groups. Specifically, the mean CRP concentration was
0.78 6 0.89 mg/dl for patients without hospitalization,
whereas it was 2.25 6 2.72 mg/dl for patients with a
hospitalization episode (P , 0.0001). Age, race, and gen- g/dl), 43% of patients were hospitalized, whereas only
17% of the patients were hospitalized in the group withder were not statistically associated with hospitalizations.
We further analyzed the data in quartiles with regard serum albumin concentrations in the highest quartile
(serum albumin more than 4.1 g/dl; Fig. 1). Reactanceto percentage of patients hospitalized in each quartile.
Figures 1, 2, and 3 depict this analysis for different ranges values also showed a similar trend with patients in the
lowest quartile (less than 38 ohms), having a 33% rateof serum albumin, reactance, and CRP, respectively.
Specifically, in the group with serum albumin concentra- of hospitalization, whereas only 16% of the patients were
hospitalized in the highest quartile (higher than 57 ohms).tions in the lowest quartile (serum albumin less than 3.7
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Fig. 4. The estimation of relative risk of hospitalization within the Fig. 5. The estimation of relative risk of hospitalization within the
subsequent three months of data collection with regard to reactancesubsequent three months of data collection with regard to serum
C-reactive protein concentrations. A serum concentration of 0.12 mg/ values. A measurement of 70 ohms is considered as the reference range
(relative risk 5 1.0). Data are controlled for all study parameters.dl is considered as the reference range (relative risk 5 1.0). Data are
controlled for all study parameters.
risk of 1.0 (average of reactance values for 75th to 100th
On the other hand, in the lowest CRP quartile (less than percentiles), the adjusted relative risk of hospitalization
0.2 mg/dl), only 15% of the patients were hospitalized, increased to 1.06 for a reactance value of 53 ohms (aver-
whereas in the highest quartile (higher than 1.4 mg/dl), age of reactance values for 50th to 75th percentile) to
48% of the patients were hospitalized. 1.09 for a reactance value of 43 ohms (average of re-
Because all of the study parameters showed significant actance values for 25th to 50th percentile) and further
differences with regard to predicting hospitalization by increased to 1.14 for a reactance value of 31 ohms (aver-
univariate analysis, a multivariate analysis was performed age of reactance values for 0 to 25th percentile).
to differentiate each parameter’s predictive power. When We further repeated multivariate analysis removing
all of the studied parameters were included within the CRP and reactance from the analyzed parameters. Se-
model, serum CRP and reactance values were the only rum transferrin was the only parameter that reached
statistically significant predictors of hospitalization (P , statistical significance in the analysis (P 5 0.045). None
0.05 for both). None of the other variables that were of the other parameters, including serum albumin, serum
significant by univariate analysis was found to be signifi- creatinine, and serum prealbumin, were statistically sig-
cant by multivariate analysis. nificantly associated with hospitalization.
In order to evaluate the adjusted relative risk of hospi-
talization with regard to different concentrations of CRP,
DISCUSSIONwe grouped CRP concentrations according to quartiles.
Figure 4 depicts a diagram of the adjusted ratio of rela- This prospective study was performed in order to eval-
uate several clinically relevant issues related to nutritiontive risk of hospitalization at several concentrations of
serum CRP. When the serum CRP concentration of 0.12 that were not studied systematically in previous studies.
First, we attempted to define the association betweenmg/dl (average of CRP values for 0 to 25th percentile)
was considered as a reference range (relative risk of 1.0), nutritional status and hospitalization as an important
measure of morbidity. We also evaluated the relationshipthere was an increase in the risk of hospitalization for
increasing serum CRP concentrations. The relative risk between inflammatory response and nutritional status
and its predictive power for hospitalization. The resultsfor hospitalization was 2% higher (relative risk 5 1.02)
for a CRP concentration of 0.38 mg/dl (average of CRP of this study strongly indicate that both inflammation
“assessed by CRP concentrations” and nutritional statusvalues for 25th to 50th percentile), 7% higher (relative
risk 5 1.07) for CRP concentration of 1.4 mg/dl (average “indicated by reactance values as a marker of lean body
mass” are independent predictors of hospitalization inof CRP values for 50th to 75th percentile), and 30%
(relative risk 5 1.30) higher for a CRP concentration CHD patients.
A series of studies has suggested that nutritional statusof 3.4 mg/dl (average of CRP values for 75th to 100th
percentile). correlates with clinical outcome in CHD patients [5, 6,
19–24]; however, many of these studies have drawbacks.Figure 5 shows a similar analysis for reactance values.
Specifically, when a reactance value of 70 ohms was An important consideration is the completeness of the
nutritional markers used for assessment of nutritionalconsidered as a reference range and assigned a relative
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status in these studies. Specifically, serum albumin has multivariate analysis, which included CRP in the model.
been the most common index of nutritional status used This is an important finding when one considers that
in many, if not all, of the available studies. It is becoming serum albumin, serum prealbumin, and serum trans-
increasingly clear that use of serum albumin as a singular ferrin are all proposed to be acute-phase reactants and
index of nutritional status is complicated by several fac- acute illnesses can trigger an abrupt decrease in their
tors. Even though serum albumin is a reliable index of concentrations independent of changes in nutrient intake
visceral protein stores, it is a rather late marker for [15, 33–35]. This implies that these markers are indeed
changes in nutrient intake and hence nutritional status influenced by inflammation and that in this particular
because of its long half-life [25–27]. In this study, a vari- group of CHD patients, they may be considered as mark-
ety of nutritional markers was used to assess both visceral ers of inflammatory response and not just nutritional
as well as somatic protein stores. The results showed a status. Although this suggests that there may be a biolog-
consistent predictive ability for all nutritional markers ical interaction between these parameters and CRP, we
with regard to hospitalization using the univariate analy- were not able find any statistically significant interactions
sis. In addition to serum albumin, serum creatinine, se- between these parameters in our multivariate analysis.
rum transferrin, and serum albumin were all capable of This may be secondary to the characteristics of our pa-
predicting hospitalization in CHD patients. Further- tient population, as well as the relatively small sample
more, reactance values, which provide an accurate re- size studied.
flection of functional capacity of lean body mass, also Morbidity was used as the primary outcome measure
significantly predicted hospitalization. in this study, which also distinguishes it from the other
Another parameter that was evaluated in this study available studies in the literature. Although mortality is
was serum CRP. CRP is a well-known nonspecific marker clearly the ultimate end point for any clinical outcomes
of inflammatory response in multiple patient popula- study, the morbidity in CHD patients represents a major
tions. It is known to increase during states of inflamma- health expenditure in the United States as well as in
tion such as infections and recent surgery. A recent study other countries. In fact, the health care cost of treating
also related CRP values to risk of myocardial infarction the U.S. ESRD program exceeds $10 billion annually,
and stroke [28]. CRP has also been evaluated in ESRD with a mean hospital admission rate of 1.72 admissions
patients and is reported to be elevated compared with per patient year at risk and length of stay of 15 hospital
healthy populations [29, 30]. This increase has been days per patient year at risk, for the average of 1994
linked to multiple factors, including effects of hemodialy- through 1996 [1]. It is therefore important to identify
sis procedure, biocompatibility of the dialysis mem- the factors that influence morbidity in CHD patients.
branes, as well as multiple hospitalizations because of
This may allow timely and appropriate interventions toinfections and/or other causes [31, 32]. Our study also
prevent subsequent hospitalizations.found CRP to be a powerful predictor of hospitalization
Other clinically relevant information that can be in-in CHD patients. Indeed, it was one of two significant
ferred from this study is that estimation of somatic pro-predictive parameters in the multivariate analysis. This
tein stores is also a reliable indicator of clinical outcome.is an expected finding given the fact that CRP is a reliable
Reactance values were significantly associated with sub-marker for inflammation in all populations, including
sequent hospitalizations in this study. Reactance valueshealthy cohorts. What is as important is that along with
were used in the study as the primary measure ratherCRP, reactance values also independently predicted hos-
than percentage lean body mass because it is this valuepitalizations in this group of CHD patients. Reactance
that predicts the viability of the metabolically active cells,is a well-established marker of lean body mass. Indeed,
that is, lean body mass, and therefore it alleviates anyit is suggested to be a more reliable marker of overall
potential flaws with unconfirmed regression equationsnutritional status than lean body mass because it directly
[16]. Once more reliable ESRD-specific equations arereflects the functional capacity of somatic protein stores.
developed, BIA may be readily used as an inexpensiveThis finding suggests that poor nutritional status, inde-
and practical method for the estimation of body composi-pendent of the presence of an inflammatory response, is
tion, and may represent an advantage when comparedalso associated with more hospitalizations. To our knowl-
with other methods (that is, dual-energy x-ray absorpti-edge, this is the first study that has systematically shown
ometry, and prompt neutron activation analysis), whichthis association between nutritional status, inflammation,
are limited because of their cost and availability.and hospitalization. It is also important to note that the
In spite of the intriguing results of this study, severaleffects of poor nutrition and inflammation are indepen-
potential shortcomings should be considered. Specifi-dent, and their concomitant presence would be additive
cally, the patient population is small and follow-up isin increasing the risk of hospitalizations in CHD patients.
limited to 15 months, which prohibits evaluation of mor-Interestingly, serum albumin as well as serum trans-
tality as a clinical outcome. It should also be noted thatferrin and serum prealbumin lost their predictive power
for hospitalization once the analysis was adjusted for the information presented in this study reflects statistical
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